Researchers looking to aggregate and harmonize genomic data—a critical undertaking that would empower translational research in pediatric oncology—will face technical complexities that exceed the challenges of enabling interoperability between electronic health record systems, said Jinghui Zhang, the St. Jude Endowed Chair in Bioinformatics and chair of the Department of Computational Biology at St. Jude Children’s Research Hospital.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
